Depletion of the diabetic gut microbiota resistance enhances stem cells therapy in type 1 diabetes mellitus
Conclusions: These results provide the rationale for a new approach to improve MSC therapy for T1DM by altering the gut microbiota.
Source: Theranostics - Category: Molecular Biology Authors: Wanqi Lv, Dana T. Graves, Linhai He, Yan Shi, Xuliang Deng, Yajun Zhao, Xian Dong, Yi Ren, Xinhua Liu, E Xiao, Yi Zhang Tags: Research Paper Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Insulin | Molecular Biology | Pancreas | Stem Cell Therapy | Stem Cells | Study | Translocation | Transplants